Winthrop Partners - WNY’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$874K Hold
729
0.43% 48
2026
Q1
$671K Buy
729
+130
+22% +$132K 0.36% 56
2025
Q4
$644K Buy
+599
New +$573K 0.35% 60
2019
Q3
$146K Hold
1,309
0.1% 125
2019
Q2
$145K Hold
1,309
0.11% 115
2019
Q1
$169K Sell
1,309
-206
-14% -$25.1K 0.13% 101
2018
Q4
$175K Hold
1,515
0.16% 98
2018
Q3
$163K Hold
1,515
0.13% 114
2018
Q2
$129K Sell
1,515
-1,365
-47% -$112K 0.11% 126
2018
Q1
$223K Hold
2,880
0.17% 112
2017
Q4
$229K Buy
+2,880
New +$245K 0.19% 112

Other funds holding LLY

Winthrop Partners - WNY's LLY Position: Q2 2026 in Review

Winthrop Partners - WNY held its Eli Lilly (LLY) position steady in Q2 2026 at 729 shares worth $874K. The position accounts for 0.43% of the portfolio, ranked #48.

Winthrop Partners - WNY first reported a position in LLY in Q4 2017 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Winthrop Partners - WNY held 729 shares of Eli Lilly worth $874K as of Q2 2026.
  • Winthrop Partners - WNY left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.43% of Winthrop Partners - WNY's portfolio in Q2 2026, its #48 holding.
  • Winthrop Partners - WNY first reported a position in Eli Lilly in Q4 2017 and has held it in 11 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Winthrop Partners - WNY's 13F filing for Q2 2026, filed 15 Jul 2026.